NCT03901937 (ω3CD) is a Phase 4 clinical trial of ω-3 polyunsaturated fatty acid in Crohn Disease, sponsored by Sir Run Run Shaw Hospital.

Who is sponsoring NCT03901937?

NCT03901937 is sponsored by Sir Run Run Shaw Hospital.

What drugs are being tested in NCT03901937?

Interventions in NCT03901937: ω-3 polyunsaturated fatty acid, Intestinal surgery for Crohn's Disease.

What condition does NCT03901937 study?

NCT03901937 studies Crohn Disease.

Is NCT03901937 still recruiting?

NCT03901937 is currently status unknown. Last updated 3 April 2019.

Last reviewed 2019-04-03 · How we verify

NCT03901937: ω3CD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effects of Parenteral ω-3 Polyunsaturated Fatty Acid on Postoperative Complications of Patients With Crohn's Disease

Status unknown Phase 4 Last updated 3 April 2019

What this trial tests

Phase 4 trial testing ω-3 polyunsaturated fatty acid in Crohn Disease in 158 participants. Status unknown.

Timeline

1 March 2019

Primary endpoint
1 September 2020

1 March 2021

Quick facts

Lead sponsor	Sir Run Run Shaw Hospital
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	158
Start date	1 March 2019
Primary completion	1 September 2020
Estimated completion	1 March 2021
Sites	1 location across China

Drugs / interventions tested

ω-3 polyunsaturated fatty acid — full drug profile →
Intestinal surgery for Crohn's Disease

Conditions studied

Crohn Disease — all drugs for Crohn Disease →

Sponsor

Sir Run Run Shaw Hospital

Who can join

Adults 18 to 75, any sex, with Crohn Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is intended to investigate the safety and efficacy of ω-3 polyunsaturated fatty acid-based parenteral nutrition (PN) for patients with Crohn's disease.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Parenteral n-3 polyunsaturated fatty acids supplementation improves postoperative recovery for patients with Crohn's disease after bowel resection: a randomized, unblinded controlled clinical trial.
Ge X, Liu H, Wu Y, Liu W, et al · · 2024 · cited 8× · PMID 38569774 · DOI 10.1016/j.ajcnut.2023.12.022
Effects of ω-3 polyunsaturated fatty acid-supplemented parenteral nutrition on postoperative complications for patients with Crohn’s disease: a cohort study
Wu Y, Liu H, Qi W, Liu W, et al · · 2020 · DOI 10.21203/rs.3.rs-55359/v1

Verify or expand the search:

Other recruiting trials for Crohn Disease

Currently open trials in the same condition.

NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
NCT07310095 — A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) · Phase 4 · recruiting
NCT07364734 — Epidemiological Characteristics and Efficacy Evaluation of Difficult-To-Treat Crohn's Disease · recruiting
NCT07170462 — Cranberry and Gut Health in Crohn's Disease · EARLY_PHASE1 · recruiting
NCT07196722 — A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease · Phase 2, PHASE3 · recruiting

Other Sir Run Run Shaw Hospital trials

Trials by the same sponsor.

NCT07453940 — Left Atrial Appendage Closure With Versus Without Pulsed Field Ablation in Atrial Fibrillation Patients With Mild Sympto · NA · recruiting
NCT07508943 — Decision-making and Optimization of Ventilatory Support for AECOPD Patients · not yet recruiting
NCT07514533 — The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma · Phase 2 · not yet recruiting
NCT07350590 — Comparison Between Robotic and Laparoscopic Right Hemicolectomy · terminated
NCT07457073 — AI-Powered Sound Analysis for COPD Screening · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03901937 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sir Run Run Shaw Hospital
Last refreshed: 3 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03901937.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing